Oncotherm
OncoTherm is a medical device used for cancer treatments.
The company was founded in 1988 by András Szász[1] in Hungary. In 2002 it received investment from a German company and was reorganized as a German-Hungarian company consisting of OncoTherm Hungary Ltd,[2] and OncoTherm GmbH.[3]
The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the hyperthermia treatment.[4] The tumor tissue has lower impedance than the surrounding tissues, so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary.[5]
Its main product is the OncoTherm EHY-2000, a hyperthermia device where thermo-electric effects of electrical fields are used. More than 450 devices have been placed into operation, mostly in Germany and S. Korea, and performed over 400,000 treatments.[6] The device is not approved by the U.S. Food and Drug Administration.
References
- ^ Andreas Szasz. "Curriculum vitae" (PDF). Retrieved 2009-06-13.
- ^ Profile listing
- ^ Profile listing
- ^ Szasz A (2007). "Hyperthermia, a modality in the wings". J Cancer Res Ther. 3 (1): 56–66. doi:10.4103/0973-1482.31976. PMID 17998724.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ "Oncothermia method | Oncotherm". oncotherm.com. Retrieved 2020-02-25.
- ^ Oncotherm Official site